This drug is indicated in patients with ulcerative colitis, Crohn‘s disease rheumatoid arthritis, ankylosing arthritis.

Mild to moderate side effect has been observed such as abdominal pain arrhythmia, liver damage, a blood disorder

This drug is to be cautiously used in patients with COPD, liver problems seizures, infection.

This drug is contraindicated in patients with heart failure, allergic reaction.

For Crohn‘s disease, ulcerative colitis, and ankylosing spondylitis- in adult usual adult dose is 5 mg /kg injection to be given intravenously at 0,2,6 weeks, thereafter 5 mg/kg every 8 weeks. For rheumatoid arthritis- In adults, a dose is 3 mg /kg injection to be given intravenously at 0,2,6 weeks and thereafter 3 mg/kg every 8 weeks.

We have also established roots and begun this new venture in other countries as well such as Russia, Poland, and Norway.